A change this past year by the us government in the way it will pay for drugs to deal with dialysis patients might have had an unintentional and potentially dire consequence, based on new information: a substantial begin bloodstream transfusions for patients who now might not be getting an adequate amount of the medicines.
The findings are noticed by some experts like a stark instance of the way the government’s compensation guidelines can drive the concept of medicine.
A policy change was intended to save cash and safeguard patient health by fixing what federal government bodies saw like a misguided financial incentive for dialysis centers to overprescribe anti-anemia drugs. Continue reading








